ONLY HEALTHCARE
The “Only Healthcare” podcast reveals shocking truths about the healthcare industry. Why are US Healthcare costs and risks so high? How will new technologies impact the system? What are the challenges in accessing new therapies and treatments? What is happening with Big Pharma and how do they influence other stakeholders in healthcare? Hosted by industry experts Michael Navin and Dr. Randy Vogenberg, to provide you with actionable and inspirational insights on how we can improve healthcare cost, care and accessibility for all.
Hosted by:
Michael Navin & Dr. Randy Vogenberg
Michael's LinkedIn
https://www.linkedin.com/in/michael-navin-7411388/
Randy's LinkedIn
https://www.linkedin.com/in/randyvogenberg/
Sponsored by:
Only Healthcare is sponsored by Peek and the Institute for Integrated Health.
Peek: Peek is reimagining access through innovation, technology, connectivity, and partnership. Peek offers a comprehensive and unique suite of solutions to help clients improve access and affordability for prescription drugs.
The Peek Meds Marketplace is one of Peek’s differentiated offerings that gives employers a revolutionary new approach to controlling runaway prescription costs for their employees by providing unprecedented transparency, simplicity - and cost savings. The Peek Meds Marketplace aggregates cash discount cards, manufacturer copay offset programs, and an employee’s insurance information to provide a holistic and personalized view of prescription price options. This easy-to-use platform offers a one-stop-shopping experience for prescription drugs.
Peek’s team has decades of experience in the pharmaceutical industry and offers various services to biopharma manufacturers, brokers, benefits consultants, third-party administrators and employers. Visit peekmeds.com to learn more.
Institute for Integrated Health (IIH):
Healthcare benefits, insurance coverage regulations, and business in the healthcare industry can be complicated. At IIH, Dr. Randy Vogenberg and his team understand these unique challenges and provide strategic guidance customized to every client. To help overcome your unique challenges, IIH delivers education, planning, and advisory on market trends and U.S. healthcare market intelligence. The firm’s decades of proven success are due to strategic collaboration with associates from the business, clinical, and scientific communities. Learn more by visiting https://iih-online.com/.
Music by:
Hanu Dixit, https://www.youtube.com/hanudixit
Disclaimer:
© 2025 Only Healthcare Podcast. All rights reserved.
This podcast and its content, including but not limited to audio recordings, images, and text, are the property of the Only Healthcare Podcast and are protected by international copyright laws. We appreciate all distribution and content sharing. Contact us at onlyhealthcarepodcast@gmail.com to access our media kits, provide feedback or inquire about guest participation. Thank you for listening.
Episodes
42 episodes
EP 42 | GLP-1s Explained: Breakthrough Therapy, Budget Disruptor, or Both?
GLP-1 medications have moved from diabetes treatment to a cultural phenomenon in record time. But beyond the headlines and celebrity endorsements lies a far more complex story.In Episode 42, Dr. Randy Vogenberg breaks down what GLP-1s ac...
.png)
Ep 41 | Healthcare 101: Who Really Controls Cost, Access, and Coverage?
In this inaugural Healthcare 101 segment, Dr. Randy Vogenberg breaks down the fundamentals of the American health insurance system. From the evolution of employer-sponsored coverage to the rise of managed care and vertical integration, this epi...
Ep 40 | Engaging the Healthcare Consumer: Transparency, Trust, and the Skills We Are Missing
In this episode of the Only Healthcare Podcast, Michael Navin and Randy Vogenberg welcome Lynn Hanessian, founder of Engager, for a wide-ranging discussion on why healthcare engagement ha...
Ep 39 | The Great American Healthcare Heist: Transparency, Power, and What Must Change
In this episode of the Only Healthcare Podcast, Michael Navin and Randy Vogenberg welcome healthcare attorney, policy advocate, and author Chris Deacon for an in-depth conversation on how stru...
.png)
Ep 38 | Rethinking Risk: How Employers Prepare for Cell and Gene Therapy
In this episode of the Only Healthcare Podcast, hosts Michael Navin and Randy Vogenberg are joined by Luke Prettol, benefits strategy leader at AT&T, for a deep dive into how employers ...
.png)
Ep 37 | Why Employers Are Reinvesting in Primary Care and What It Means for Cost, Care, and Engagement
Employers are no longer waiting for healthcare costs to stabilize. In this episode, Randy Vogenberg and Michael Navin are joined by Murray Harbour to break down why advanced primary care, direct contracting, and value-based benefit design are m...
Ep 36 | Drug Pricing at the Center: IRA, MFN, and Employer Direct Purchasing in 2026
In this episode of the Only Healthcare Podcast, hosts Michael Navin and Dr. Randy Vogenberg welcome back Jayson Slotnick for a fast-moving year-in-review of 2025 and a grounded outlook for 2026. The conversation breaks down what changed through...
Ep 35 | Healthcare at a Breaking Point: Costs, Policy Gridlock, and What 2026 Holds
In this episode of the Only Healthcare Podcast, hosts Michael Navin and Randy Vogenberg welcome back healthcare policy veteran Deborah Williams for a candid conversation on why 2025 became such a difficult year for employers, patients, and poli...
.png)
Ep 34 | ACNU Explained: How FDA’s New Nonprescription Pathway Could Expand Access and Improve Adherence
Recorded live at the Nicholas Hall North American Conference, this special episode of the Only Healthcare Podcast dives into the FDA’s new Additional Conditions for Nonprescription Use (ACNU) pathway and what it means for access, complia...
Ep 33 | Year in Review: The Healthcare Shifts That Defined 2025 and What’s Ahead in 2026
In this year-end episode of the Only Healthcare Podcast, hosts Randy Vogenberg and Michael Navin reflect on the defining healthcare shifts of 2025 and share what they are watching as the industry moves into 2026 and beyond....
.png)
Ep 32 | Exploring AI Patient Care and Clinical Decision Making with Carole Tremonti
In this episode of the Only Healthcare Podcast, host Randy Vogenberg, PhD, is joined by Carole Tremonti of ConcertAI to ...
.png)
Ep 31 | The Next Chapter of Oncology Pathways: AI, Transparency, and What’s Next
In this episode of the Only Healthcare Podcast, host Randy Vogenberg, PhD, sits down with consultant and longtime oncology pathways leader Gordon Kuntz to explore the evolution of the Clinical Pathways Congress and a new initiative focused on p...
.png)
Ep 30 | ACNU Live Panels Follow-Up: Deep Dive Virtual Panel On FDA’s New ACNU Rule
In this episode of the Only Healthcare Podcast, co-host Randy Vogenberg, PhD moves beyond the Nicholas Hall North America Conference to break down the FDA’s new Additional Conditions for Nonprescription. Guests
.png)
Ep 29 | The Future of the Journal of Clinical Pathways with Winston Wong
In this episode of the Only Healthcare Podcast, co-host Randy Vogenberg, PhD, sits down with Winston Wong, Editor-in-Chief of the Journal of Clinical Pathways, to explore the past, present, and future of one of the most influential pub...
Ep 28 | Insights from Health Rosetta Fest 2025
In this episode of the Only Healthcare Podcast, hosts Randy Vogenberg, PhD, and Michael Navin unpack key insights from Health Rosetta Fest 2025, held in Denver, Colorado. This year’s event brought together more tha...
Ep 27 | Nicholas Hall Panel Discussion 2: Nonprescription Access to Drug Treatment
In this episode of the Only Healthcare Podcast, recorded live at the Nicholas Hall North America Conference, our panel explores how the FDA’s new Additional Conditions for Nonprescription Use (ACNU) rule could transform chronic ...
EP 26 | OHPLive! Non prescription access to drug treatment
In this episode of the Only Healthcare Podcast, recorded live at the Nicholas Hall North America Conference, our panel explores how the FDA’s new Additional Condition for Nonprescription Use (ACNU) rule is reshaping the future of ...
Breaking Down the $80 Billion 340B Drug Program with William Sarraille | Only Healthcare Podcast #25
In this episode of Only Healthcare, host Randy Vogenberg welcomes William Sarraille, retired senior partner from Sidley Austin's healthcare practice and nationally recognized expert in US healthcare law. As both a legal authority and rare di...
.png)
How Cell and Gene Therapies Can Bankrupt Unprepared Employers with Tom Sondergeld | Only Healthcare Podcast #24
In this episode of Only Healthcare's Risk Series, hosts Michael Navin and Randy Vogenberg welcome Tom Sondergeld, managing partner of TS Consulting Group with over 30 years in healthcare benefit consulting and former senior advisor to McKins...
Healthcare’s Lightning Strike Cost Problem with Drew Wilkins | Only Healthcare Podcast #23
In this episode of Only Healthcare's Risk Series, hosts Michael Navin and Randy Vogenberg welcome Drew Wilkins, Managing Director at Monitor Deloitte with over 20 years of consulting experience in corporate strategy and innovation. As an exp...
.png)
The Hidden Agenda of Healthcare Insurance with Tamara Thomas | Only Healthcare Podcast #22
In this episode of Only Healthcare, hosts Randy Vogenberg and Michael Navin welcome Tamara Thomas, Founder and Editor-in-Chief of Urban Health Today, for a candid discussion about the consumer perspective on America's broken healthcare syste...
Breaking the Healthcare Monopoly with Dave Chase and Steve Ditto | Only Healthcare Podcast #21
In this episode of Only Healthcare, hosts Michael Navin and Dr. Randy Vogenberg welcome two healthcare transformation pioneers: Dave Chase, co-founder of Health Rosetta, and Steve Ditto,...
GLP-1s: The Billion Dollar Dilemma in US Healthcare with Deborah Williams | Only Healthcare Podcast #20
In this episode of Only Healthcare, hosts Michael Navin and Dr. Randy Vogenberg welcome guest Deborah Williams, a leading healthcare strategy and policy expert, to explore the explosive growth and complex economics of GLP-1 medications like ...
Why Are Prescription Drugs So Expensive with Michael Navin & Dr. Randy Vogenberg | Only Healthcare Podcast #19
In this episode of Only Healthcare, hosts Michael Navin and Dr. Randy Vogenberg dive deep into one of America's most pressing healthcare questions: Why are prescription drugs so expensive? Michael, a leading expert in biot...
Why the US Spends the Most on Healthcare But Gets the Worst Outcomes with Dr. Randy Vogenberg & Michael Navin | Only Healthcare Podcast #18
In this episode of Only Healthcare, we tackle the fundamental question: Why does the US spend more on healthcare than any other country yet rank last in outcomes? Key Topics:The cost-outcome paradox – How $12,...
